# A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

> **NCT05454709** · PHASE2 · WITHDRAWN · sponsor: **Inreda Diabetic B.V.**

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Dasiglucagon
- **DRUG:** GlucaGen

## Key facts

- **NCT ID:** NCT05454709
- **Lead sponsor:** Inreda Diabetic B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-29
- **Primary completion:** 2023-12-29
- **Final completion:** 2023-12-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study medication could not be delivered by manufacturer.
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05454709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05454709, "A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05454709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*